Analytical applications of aptamers
2005, Biosensors and Bioelectronics
https://doi.org/10.1016/J.BIOS.2004.11.006…
1 page
1 file
Sign up for access to the world's latest research
Related papers
2009
Aptamers define a new interesting class of receptor molecules with capability of binding to potentially any kind of molecules of interest. Structurally, they are composed of nucleic acids (RNA, DNA or a mixture of both) with high specificity and affinity to amino acids, drugs, proteins and other molecules. Apatmers are isolated from complex libraries of synthetic nucleic acids against the desired target molecules. They can be chemically modified to increase their stability and availability in biological environments. These molecules have potential applications in diagnostic assays such as conventional immunoassays, and in analytical devices including biosensors. Aptamers have been recently applied as antibodies against viral antigens and several key target molecules in cellular metabolic pathways. In this article, aptamers and their application in nanomedicine have been reviewed.
Biomedical Journal of Scientific & Technical Research, 2020
Nucleic acids that can bind with high affinity and specificity to target molecules are called "aptamers". Aptamers are single-stranded nucleic acids that directly inhibit a protein's function by folding into a specific three-dimensional structure that dictates high-affinity binding to the targeted protein. Aptamers exhibit significant advantages relative to protein therapeutics in terms of size, synthetic accessibility, and modification by medicinal chemistry. Despite these properties, aptamers have been slow to reach the marketplace, with only one aptamer-based drug receiving approval so far. Recently, aptamers constitute a new class of oligonucleotides that have gained therapeutic importance and pegaptanib is the first approved aptamer drug that is class of oligonucleotides and is often referred to as 'chemical antibodies. The development of pegaptanib is looked at for the challenges faced in converting aptamers into therapeutic molecules. Because they inhibit the activity of existing proteins directly, aptamers are more similar to a monoclonal antibody or small molecule drugs than to antisense compounds, and this property greatly increases the number of clinical indications that are potentially treatable by nucleic acid-based compounds.
TrAC Trends in Analytical Chemistry, 2006
Advances in systematic evolution of ligands by exponential enrichment (SELEX), a selection protocol for aptamers, have resulted in increased applications of DNA and RNA aptamers in developing analytical techniques. We review recent developments in SELEX techniques as well as new aptamerbased bioanalytical applications. ª
ChemBioChem, 2003
Nucleic acid aptamers are molecules that bind to their ligands with high affinity and specificity. Unlike other functional nucleic acids such as antisense oligonucleotides, ribozymes, or siRNAs, aptamers almost never exert their effects on the genetic level. They manipulate their target molecules such as gene products or epitopes directly and site specifically, leaving nontargeted protein functions intact. In a similar way to antibodies, aptamers bind to many different kinds of target molecules with high specificity and can be made to order, but as a result of their different biochemical nature and size they can also be used complementary to antibodies. In some cases, aptamers might be more suitable or more specific than antibody approaches or small molecules, both as scientific and biotechnological tools and as therapeutic agents. Recent examples of characterization of aptamers as tools for scientific research to study regulatory circuits, as tools in diagnostic or biosensor development, and as therapeutic agents are discussed.
Analytical Biochemistry, 2020
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Nature Protocols, 2006
E. Coli Infections - Importance of Early Diagnosis and Efficient Treatment, 2019
Aptamers are in vitro-selected, nucleic acids with unique abilities to bind strongly and specifically to their selective targets (ligands) based on their threedimensional structures. Target binding is generally associated with a change in aptamer structure, which provides a means of linking many output signals to the binding event. Being synthetic, aptamers are less expensive compared to antibodies. Aptamers are also more easily modified chemically or their sequence changed to optimize properties such target specificity, storability and stability. In this chapter we will discuss the potential benefits of applying aptamers to diagnostics with a focus on infectious disease and the unique challenges posed by aptamers for their successful incorporation into reliable aptasensors.
Galen Medical Journal, 2019
Background: The apply of aptamers as a new generation's way to probe diagnostic for the detection of target molecules has gained ground. Aptamers can be used as alternatives to diagnostic antibodies for detection of blood groups due to their unique features. This study was aimed to produce DNA diagnostic aptamer detecting the antigen of A 1 blood group using the Cell-Selex method. Materials and Methods: DNA aptamer was isolated against A 1 RBC antigen after ten stages of Cell-Selex and amplification by an asymmetric polymerase chain reaction. The progress of the stages of selection was evaluated using flow cytometry analysis, which the DNA aptamer isolated from the tenth cycle with an affinity of 70% fluorescent intensity, was selected from four positive colonies followed by determination of the sequences and secondary structures. Results: The aptameric sequence obtained from C 4 cloning was calculated with the highest binding affinity to A 1 antigen having an apparent dissociation constant (Kd value) of at least 29.5 ± 4.3 Pmol, which was introduced as the selected aptamer-based on ΔG obtained from a colony of C 4 equal to-13.13. Conclusion: The aptamer obtained from using Cell-Selex method could be used as an example for the development of diagnostic tools such as biosen-sors for detecting A 1 blood group antigens.
Disease and Molecular Medicine, 2013
Aptamers are nucleic acid oligomers with distinct conformational shapes that allow binding targets with high affinity and specificity. Selective Evolution of Ligands by Exponential Enrichment (SELEX); an in vitro selection process to develop aptamers, has been invented in 1990. Despite more than 20 years have passed after its discovery, products of SELEX technology are in use in medicine. In this review we discuss why we need aptamers not only in therapeutic but also in diagnostic applications; and also critical points in SELEX technology. Finally; we present the aptamers in use and some patented aptamers awaiting approval. 'to fit' and the Greek word 'meros' meaning 'particle'. An aptamer is a DNA or RNA oligonucleotide that has
Pharmaceuticals, 2011
Aptamers are nucleic acid-based ligands identified through a process of molecular evolution named SELEX (Systematic Evolution of Ligands by Exponential enrichment). During the last 10-15 years, numerous aptamers have been developed specifically against targets present on or associated with the surface of human cells or infectious pathogens such as viruses, bacteria, fungi or parasites. Several of the aptamers have been described as potent probes, rivalling antibodies, for use in flow cytometry or microscopy. Some have also been used as drugs by inhibiting or activating functions of their targets in a manner similar to neutralizing or agonistic antibodies. Additionally, it is straightforward to conjugate aptamers to other agents without losing their affinity and they have successfully been used in vitro and in vivo to deliver drugs, siRNA, nanoparticles or contrast agents to target cells. Hence, aptamers identified against cell surface biomarkers represent a promising class of ligands. This review presents the different strategies of SELEX that have been developed to identify aptamers for cell surface-associated proteins as well as some of the methods that are used to study their binding on living cells.

Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.